Hatch-Waxman ANDA Litigation Forum
Our group is one of the longest-running discussion groups dedicated to patents, patent litigation and FDA regulatory issues relating to the U.S. generic drug market. Our members include top industry experts from pharma, generic drug companies, lawyers, litigators, analysts, educators, and anyone else examining generic drugs and biosimilars. No other group offers the top experts on NDA, ANDA, 505(b)(2), BLA, ABLA, 351(k), and any other drug application filed with FDA in the United States. All comments are intended for only personal use, rumination and reflection, and are not to and shall not be imputed to any particular company or entity. We are not your lawyer.